BioSpace News Archive

Deals

Zymeworks Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Over-Allotment Option to Purchase Additional Shares - Jan. 27, 2020

Zymeworks Inc., a clinical stage biopharmaceutical company developing multifunctional biotherapeutics, announced the closing of its previously announced underwritten public offering.

January 27, 2020
·
6 min read
Business

BIOTRONIK, Inc. Appoints David Hayes, MD, as Chief Medical Officer

BIOTRONIK, Inc. today announced the appointment of David Hayes, MD, FACC, as Chief Medical Officer

January 27, 2020
·
3 min read
Deals

IBEX Grants Stock Options

IBEX Technologies Inc. announces that on January 23, 2020, its Board of Directors granted 455,000 stock options to Board Members and staff to replace options that expired on December 19, 2019.

January 27, 2020
·
1 min read
Pharm Country

Feinstein Institutes Unveil First Long-term Vagus Nerve Stimulation Implant in Mice

This new standard in bioelectronic medicine research demonstrates the potential impact of long-term vagus nerve stimulation to treat a wide range of diseases and conditions

January 27, 2020
·
3 min read
Profound Medical Announces Closing of Offering

Profound Medical Corp. (TSX:PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce that it has closed its previously-announced underwritten offering (the “Offering”) of common shares of the Company (the “Common Shares”) at a price of US$11.65 per Common Share.

January 27, 2020
·
5 min read
Business

Dr. Ioannis Skaribas, M.D., FASA, DABA Performs the First Abbott Proclaim XR™ Spinal Cord Stimulator Procedure in Houston, TX

Dr. Ioannis Skaribas, a leader in Interventional Pain Management, is the first physician in his region to perform a spinal cord stimulator implant with the new Abbott Proclaim XR™ neurostimulation system.

January 27, 2020
·
1 min read
Biotech Bay

uLab Systems Secures $18M in Series D Financing Led by Park West

uLab Systems, the creator of the state-of-the-art aligner planning software, has completed an $18M Series D financing round led by Park West Asset Management and supported by minority investors including Ortho Studio Express.

January 27, 2020
·
1 min read
Policy

Notice to the Media - Public Health Agency of Canada - The Chief Public Health Officer and the Deputy Chief Public Health Officer to hold a media availability on a novel coronavirus

The Chief Public Health Officer, Dr. Theresa Tam, and the Deputy Chief Public Health Officer, Dr. Howard Njoo, will hold a media availability to provide an update on a novel coronavirus..

January 27, 2020
·
1 min read
Business

The HydraFacial™ Company Partners with Dr. Paul Nassif & NassifMD Dermaceuticals™

The HydraFacial™ Company announced today that they have partnered with Dr. Paul Nassif and NassifMD Dermaceuticals™ to launch Hydraglucan™ Intense Hydration Booster.

January 27, 2020
·
3 min read
Drug Development

OncoImmune Announces Presentation of CD24Fc Phase IIa Data and Phase III Clinical Trial Design at the 2020 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

OncoImmune, Inc. announced that clinical data from its Phase IIa clinical trial of CD24Fc are being presented at the 2020 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Meeting, taking place in Orlando, Florida in February.

January 27, 2020
·
3 min read